Neuren Pharmaceuticals Annual Report 2024

COVER	1
NEUREN’S VALUE PROPOSITION	3
CHAIR AND CEO MESSAGE	4
OPERATING REVIEW	6
BOARD	16
EXECUTIVE TEAM	17
ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG)	18
DIRECTORS’ RESPONSIBILITIES STATEMENT	25
CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME	26
CONSOLIDATED STATEMENT OF FINANCIAL POSITION	27
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY	28
CONSOLIDATED STATEMENT OF CASH FLOWS	29
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS	30
INDEPENDENT AUDITOR’S REPORT	50
ADDITIONAL INFORMATION	53

RkJQdWJsaXNoZXIy MjE2NDg3